First Trust Advisors LP lessened its position in Xylem Inc (NYSE:XYL) by 50.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 371,032 shares of the industrial products company’s stock after selling 384,383 shares during the period. First Trust Advisors LP owned approximately 0.21% of Xylem worth $29,634,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the stock. Morgan Stanley increased its stake in Xylem by 43.1% during the 2nd quarter. Morgan Stanley now owns 1,175,977 shares of the industrial products company’s stock valued at $79,238,000 after buying an additional 354,340 shares during the period. Notis McConarty Edward increased its stake in Xylem by 5.9% during the 3rd quarter. Notis McConarty Edward now owns 17,945 shares of the industrial products company’s stock valued at $1,433,000 after buying an additional 1,000 shares during the period. Strs Ohio increased its stake in Xylem by 27.4% during the 2nd quarter. Strs Ohio now owns 30,837 shares of the industrial products company’s stock valued at $2,077,000 after buying an additional 6,630 shares during the period. Private Advisor Group LLC acquired a new position in Xylem during the 2nd quarter valued at about $747,000. Finally, AMP Capital Investors Ltd increased its stake in Xylem by 14.0% during the 2nd quarter. AMP Capital Investors Ltd now owns 84,894 shares of the industrial products company’s stock valued at $5,720,000 after buying an additional 10,405 shares during the period. 84.53% of the stock is currently owned by institutional investors and hedge funds.
In other Xylem news, insider Paul A. Stellato sold 3,000 shares of the firm’s stock in a transaction dated Monday, September 10th. The shares were sold at an average price of $78.63, for a total value of $235,890.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Paul A. Stellato sold 1,500 shares of the firm’s stock in a transaction dated Wednesday, September 19th. The stock was sold at an average price of $82.00, for a total transaction of $123,000.00. Following the completion of the transaction, the insider now owns 12,796 shares of the company’s stock, valued at $1,049,272. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 29,161 shares of company stock valued at $2,327,231. Insiders own 0.81% of the company’s stock.
Several equities analysts have commented on XYL shares. Vertical Research cut shares of Xylem from a “hold” rating to a “sell” rating in a research note on Monday, October 8th. Credit Suisse Group started coverage on shares of Xylem in a research note on Friday, October 12th. They set an “outperform” rating and a $86.00 target price on the stock. Berenberg Bank started coverage on shares of Xylem in a research note on Wednesday, October 3rd. They set a “sell” rating and a $65.00 target price on the stock. Zacks Investment Research raised shares of Xylem from a “sell” rating to a “hold” rating and set a $84.00 target price on the stock in a research note on Thursday, August 2nd. Finally, Royal Bank of Canada reissued a “buy” rating and set a $77.00 target price on shares of Xylem in a research note on Wednesday. One analyst has rated the stock with a sell rating, six have given a hold rating and eight have given a buy rating to the stock. Xylem has a consensus rating of “Hold” and an average target price of $79.57.
NYSE:XYL opened at $68.02 on Friday. Xylem Inc has a twelve month low of $63.71 and a twelve month high of $82.44. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.49 and a quick ratio of 1.02. The stock has a market cap of $12.22 billion, a PE ratio of 28.34, a price-to-earnings-growth ratio of 1.31 and a beta of 1.24.
Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, October 30th. The industrial products company reported $0.77 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.77. Xylem had a net margin of 7.75% and a return on equity of 19.54%. The company had revenue of $1.29 billion during the quarter, compared to analyst estimates of $1.30 billion. During the same quarter last year, the firm posted $0.65 EPS. The business’s revenue for the quarter was up 7.7% on a year-over-year basis. Equities research analysts expect that Xylem Inc will post 2.89 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 7th. Stockholders of record on Thursday, November 1st will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Wednesday, October 31st. This represents a $0.84 annualized dividend and a dividend yield of 1.23%. Xylem’s dividend payout ratio (DPR) is 35.00%.
Xylem Company Profile
Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.
Featured Article: How Do You Calculate Return on Equity (ROE)?
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.